Adial Pharmaceuticals Inc (ADIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,893 | -7,424 | -4,088 | -2,277 | -8,591 |
| Depreciation Amortization | 1 | 0 | 0 | 0 | 1 |
| Other Working Capital | 637 | 760 | 311 | -119 | 208 |
| Other Operating Activity | 2,622 | 1,644 | 966 | 571 | 2,044 |
| Operating Cash Flow | $-7,633 | $-5,019 | $-2,811 | $-1,825 | $-6,339 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | -350 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-350 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,607 | 5,607 | 4,657 | N/A | 9,247 |
| Financing Cash Flow | $5,607 | $5,607 | $4,657 | $N/A | $9,247 |
| Beginning Cash Position | 6,777 | 6,777 | 6,777 | 6,777 | 3,869 |
| End Cash Position | 4,401 | 7,365 | 8,624 | 4,952 | 6,777 |
| Net Cash Flow | $-2,376 | $588 | $1,847 | $-1,825 | $2,908 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,633 | -5,019 | -2,811 | -1,825 | -6,339 |
| Free Cash Flow | -7,633 | -5,019 | -2,811 | -1,825 | -6,339 |